| Product Code: ETC4471825 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The India Blood Screening market plays a crucial role in ensuring the safety of blood transfusions and preventing the spread of transfusion-transmitted infections. With an increasing number of blood donations and blood-related procedures, the demand for accurate and high-throughput screening has risen. Nucleic acid testing (NAT), enzyme immunoassays, and serological tests are some of the key methods employed for blood screening. Regulatory measures and advancements in screening technologies have significantly improved the reliability and efficiency of the process, making blood transfusion safer and more reliable. This market is expected to continue growing as healthcare infrastructure expands and blood safety remains a top priority.
The India blood screening market is driven by several factors, including the increasing awareness of bloodborne diseases, a growing need for safe blood transfusions, and stringent regulatory requirements. Additionally, the rising prevalence of infectious diseases such as HIV and hepatitis has boosted demand for advanced blood screening technologies and diagnostic tests. Continuous technological advancements and a surge in healthcare infrastructure also contribute to the market`s growth.
Challenges in the India blood screening market revolve around the need for advanced technology, safety, and regulatory compliance. Ensuring the safety of blood transfusions is a primary concern, and this requires advanced screening methods. Maintaining strict regulatory standards and quality control to prevent the transmission of infectious diseases through blood transfusions is challenging, especially in a country as diverse and large as India.
The blood screening market experienced fluctuations due to COVID-19. While the demand for blood and blood products remained essential, the pandemic led to disruptions in blood collection drives and donor shortages. Safety measures were heightened to ensure the safety of blood donors and recipients.
Key players in the India Blood Screening market include Abbott Laboratories, Grifols, Roche Diagnostics, Bio-Rad Laboratories, and Siemens Healthineers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Blood Screening Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Blood Screening Market Revenues & Volume, 2021 & 2031F |
3.3 India Blood Screening Market - Industry Life Cycle |
3.4 India Blood Screening Market - Porter's Five Forces |
3.5 India Blood Screening Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Blood Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 India Blood Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Blood Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about blood-borne diseases and the importance of blood screening |
4.2.2 Growing demand for blood screening due to rising incidences of infectious diseases |
4.2.3 Government initiatives promoting healthcare infrastructure and blood safety measures |
4.3 Market Restraints |
4.3.1 High cost associated with advanced blood screening technologies |
4.3.2 Limited access to blood screening facilities in rural areas |
4.3.3 Lack of skilled healthcare professionals for conducting blood screening tests |
5 India Blood Screening Market Trends |
6 India Blood Screening Market, By Types |
6.1 India Blood Screening Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Blood Screening Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 India Blood Screening Market Revenues & Volume, By Instruments, 2021-2031F |
6.1.4 India Blood Screening Market Revenues & Volume, By Reagents & Kits, 2021-2031F |
6.2 India Blood Screening Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Blood Screening Market Revenues & Volume, By Molecular Tests, 2021-2031F |
6.2.3 India Blood Screening Market Revenues & Volume, By Serology Tests, 2021-2031F |
6.3 India Blood Screening Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Blood Screening Market Revenues & Volume, By Independent Clinical Laboratories, 2021-2031F |
6.3.3 India Blood Screening Market Revenues & Volume, By Hospital-based Laboratories, 2021-2031F |
6.3.4 India Blood Screening Market Revenues & Volume, By Others, 2021-2031F |
7 India Blood Screening Market Import-Export Trade Statistics |
7.1 India Blood Screening Market Export to Major Countries |
7.2 India Blood Screening Market Imports from Major Countries |
8 India Blood Screening Market Key Performance Indicators |
8.1 Percentage increase in the number of blood screening tests conducted annually |
8.2 Adoption rate of advanced blood screening technologies in healthcare facilities |
8.3 Percentage of population covered by government-funded blood screening programs |
8.4 Average turnaround time for blood screening test results |
8.5 Rate of compliance with blood safety regulations and standards |
9 India Blood Screening Market - Opportunity Assessment |
9.1 India Blood Screening Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Blood Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 India Blood Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Blood Screening Market - Competitive Landscape |
10.1 India Blood Screening Market Revenue Share, By Companies, 2024 |
10.2 India Blood Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |